Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cushing's syndrome
Cushing's syndrome
Teva sues Corcept over mifepristone 'monopoly' for rare disorder
Reuters
Fri, 06/14/24 - 11:09 am
Teva Pharmaceutical
Corcept Therapeutics
legal
Korlym
Cushing's syndrome
mifepristone
Xeris Biopharma scores FDA approval for endogenous Cushing's syndrome drug Recorlev
Fierce Pharma
Thu, 12/30/21 - 07:40 pm
Xeris Biopharma
FDA
Cushing's syndrome
Recorlev
HRA Pharma debuts one-stop hub for rare disease Cushing’s syndrome aimed at physicians
Fierce Pharma
Fri, 03/19/21 - 10:52 am
HRA Pharma
Cushing's syndrome
physicians
pharma marketing
Novartis orphan drug Signifor gets another approval
Fierce Pharma
Mon, 12/17/12 - 01:31 pm
Signifor
Novartis
Cushing's syndrome
FDA
Corcept Therapeutics: Korlym Is Available Now
Seeking Alpha
Thu, 04/26/12 - 11:14 am
Corcept Therapeutics
Korlym
Cushing's syndrome
Corcept Therapeutics' Korlym to ship to patients by April 11
Yahoo/Fly on the Wall
Thu, 03/22/12 - 11:32 am
Corcept Therapeutics
Korlym
Cushing's syndrome
Corcept Scores A First With Cushing's Treatment Approval In The U.S.
Seeking Alpha
Tue, 02/21/12 - 09:34 am
Cushing's syndrome
Corcept Therapeutics
Korlym
Novartis
Signifor
Corcept Therapeutics Incorporated Announces FDA Approval of Korlym(TM) (Mifepristone): First and Only Approved Medication for Cushing's Syndrome Patients
Yahoo/MarketWire
Sat, 02/18/12 - 12:21 pm
Corcept Therapeutics
Korlym
Cushing's syndrome
The Big Bet on Corcept
Motley Fool
Thu, 02/16/12 - 05:21 pm
Corcept
Korlym
Cushing's syndrome
Catalysts On Tap For Corcept Therapeutics
Seeking Alpha
Tue, 02/7/12 - 10:37 am
Corcept Therapeutics
Korlym
Cushing's syndrome
Corlux
Corcept Therapeutics details Corlux study results
Yahoo/AP
Mon, 06/6/11 - 09:33 pm
Corcept Therapeutics
Corlux
Cushing's syndrome
Corcept Therapeutics Announces Detailed Findings From Phase 3 Study Which Show CORLUX Significantly Improves Clinical and Metabolic Manifestations of Cushing's Syndrome
Yahoo/MarketWire
Sun, 06/5/11 - 10:01 am
Corcept Therapeutics
Corlux
Cushing's syndrome
What's Next for Shares of Corcept Therapeutics
Minyanville
Tue, 01/18/11 - 11:28 am
Corcept Therapeutics
Cushing's syndrome